InvestorsHub Logo
Followers 22
Posts 747
Boards Moderated 0
Alias Born 09/07/2016

Re: jomama9231 post# 230872

Friday, 11/29/2019 11:12:46 PM

Friday, November 29, 2019 11:12:46 PM

Post# of 429056
Jomamma - totally understand your point. I wouldn't want to be at risk for an MI or stroke and be taking an MTNB drug either when I know Vascepa gave a 25% benefit with a p value of 7 0's. On the other hand there's got to be ways to identify new drugs which may be beneficial in a similar class. Lipitor and Crestor appear to be better then their early statin counterparts. Although I'd be very surprise to see MTNB, Acasti or Epanova surpass the results of the RI trial.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News